|
Denikitug Clinical Trials
1 actively recruiting trial across 1 location
▼ -1 trial since August 2026
Also known as: DEN, GS-1811
Pipeline
Phase 2: 1
Top Sponsors
- Gilead Sciences1
Indications
- Advanced Microsatellite Stable Colorectal Cancer1
- Cancer1
North Haven, Connecticut1 trial
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
Yale-New Haven Hospital - Yale Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.